Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived

Parthika Patel31 July 2025 1:49 PM IST

New Delhi: Zydus Lifesciences Limited has been directed to conduct a Phase III clinical trial in the Indian population for its proposed oncology drug...

AbbVie Eyes USD 1 Billion Buyout of Mental Health Drugmaker Gilgamesh

Parthika Patel31 July 2025 10:30 AM IST

Bengaluru: Drugmaker AbbVie is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about...

GSK Raises Outlook After Q2 Beat, Eyes USD 53.44B Sales by 2031

Parthika Patel31 July 2025 10:15 AM IST

Bengaluru: British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after second-quarter sales and earnings...

CDSCO Introduces QR Code System for Streamlined Visitor Entry

Parthika Patel30 July 2025 3:53 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has launched a new QR code-based online appointment system to simplify the process...

NPPA Approves Separate Price for GSK's New Paracetamol-Phenylephrine Sachet

Parthika Patel29 July 2025 10:12 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has...

Ranitidine Under Cancer Cloud: CDSCO Calls for Monitoring NDMA Levels, Shelf Life Cuts

Parthika Patel28 July 2025 6:27 PM IST

New Delhi: The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a directive to all...

E-Pharmacy Threat Growing Unchecked: AIOCD Flags Regulatory Failure, Calls for Urgent CDSCO Action

Parthika Patel28 July 2025 6:25 PM IST

New Delhi: The All-India Organisation of Chemists and Druggists (AIOCD) has raised serious concerns over the illegal sale of prescription medicines by...

Goa unveils lifesaving therapies pricing policy

Expert Committee Clears Ravenbhel to Begin Resmetirom Phase 3 Trial, Asks for BE Data First

Parthika Patel27 July 2025 4:00 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Gastroenterology and Hepatology division of the Central Drugs Standard Control Organisation...

NPPA Warns Drugmakers Against Arbitrary Pricing, Calls for MRP Uniformity

Parthika Patel26 July 2025 10:52 PM IST

New Delhi: In a move to ensure uniform pricing and check arbitrary price differences across pharmaceutical brands, the National Pharmaceutical Pricing...

NPPA Committee Asks Intas to Clarify Patent Discrepancy in Clozapine ER Pricing Plea

Parthika Patel26 July 2025 8:47 PM IST

New Delhi: The Multidisciplinary Committee (MDC) of Experts under the National Pharmaceutical Pricing Authority (NPPA) has asked Intas Pharmaceuticals...

CDSCO Panel Seeks Safety Data on 5% Lenalidomide TDS Before Clearing 8% Patch Trial

Parthika Patel25 July 2025 4:38 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Oncology division of the Central Drugs Standard Control Organisation (CDSCO) has not granted...

CDSCO Panel Approves Phase IV Protocol Amendment for Bristol-Myers Squibb's Mavacamten Study

Parthika Patel24 July 2025 6:49 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok